BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 26277244)

  • 21. Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake.
    Labrie M; Lalonde S; Najyb O; Thiery M; Daneault C; Des Rosiers C; Rassart E; Mounier C
    PLoS One; 2015; 10(6):e0130230. PubMed ID: 26083030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet-dependent alterations of hepatic Scd1 expression are accompanied by differences in promoter methylation.
    Schwenk RW; Jonas W; Ernst SB; Kammel A; Jähnert M; Schürmann A
    Horm Metab Res; 2013 Oct; 45(11):786-94. PubMed ID: 23803969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver.
    Guillén N; Navarro MA; Arnal C; Noone E; Arbonés-Mainar JM; Acín S; Surra JC; Muniesa P; Roche HM; Osada J
    Physiol Genomics; 2009 May; 37(3):187-98. PubMed ID: 19258494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
    Yamazaki T; Kishimoto K; Miura S; Ezaki O
    J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
    Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
    Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
    Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
    Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
    Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen TM; Zhu X; Duong MN; Brown AL; Lord C; Shah R; Davis MA; Kelley K; Wilson MD; Madenspacher J; Fessler MB; Parks JS; Rudel LL
    Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):24-30. PubMed ID: 19834103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling.
    Fell GL; Cho BS; Dao DT; Anez-Bustillos L; Baker MA; Nandivada P; Pan A; O'Loughlin AA; Mitchell PD; Nose V; Gura KM; Puder M
    Prostaglandins Leukot Essent Fatty Acids; 2019 Apr; 143():8-14. PubMed ID: 30975380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine.
    de Wit N; Derrien M; Bosch-Vermeulen H; Oosterink E; Keshtkar S; Duval C; de Vogel-van den Bosch J; Kleerebezem M; Müller M; van der Meer R
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G589-99. PubMed ID: 22700822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.
    Chen J; Wang W; Qi Y; Kaczorowski D; McCaughan GW; Gamble JR; Don AS; Gao X; Vadas MA; Xia P
    Biochim Biophys Acta; 2016 Feb; 1861(2):138-147. PubMed ID: 26615875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice.
    Kajikawa S; Harada T; Kawashima A; Imada K; Mizuguchi K
    Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):229-38. PubMed ID: 19328666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIF-dependent Toll-like receptor signaling suppresses
    Chen J; Li J; Yiu JHC; Lam JKW; Wong CM; Dorweiler B; Xu A; Woo CW
    Sci Signal; 2017 Aug; 10(491):. PubMed ID: 28790196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A diet high in α-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats.
    Hanke D; Zahradka P; Mohankumar SK; Clark JL; Taylor CG
    Prostaglandins Leukot Essent Fatty Acids; 2013; 89(6):391-401. PubMed ID: 24140006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated fatty acids.
    Landschulz KT; Jump DB; MacDougald OA; Lane MD
    Biochem Biophys Res Commun; 1994 Apr; 200(2):763-8. PubMed ID: 7910016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
    Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and reversal of hepatic steatosis with a high-protein diet in mice.
    Garcia-Caraballo SC; Comhair TM; Verheyen F; Gaemers I; Schaap FG; Houten SM; Hakvoort TB; Dejong CH; Lamers WH; Koehler SE
    Biochim Biophys Acta; 2013 May; 1832(5):685-95. PubMed ID: 23410526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression.
    Mwangi SM; Peng S; Nezami BG; Thorn N; Farris AB; Jain S; Laroui H; Merlin D; Anania F; Srinivasan S
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G103-16. PubMed ID: 26564715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.